FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Watch: The Priceless Look on This Sign Language Interpreter’s Face When She Has to Sign Hateful Islamic Verses She Probably Never Knew Existed

Denver mayor orders ICE agents detained if they ‘assault or shoot’ residents

Travis County DA faces renewed ‘soft on crime’ criticism after career criminal charged with murder

Perfect Justice: Bill Gates Confesses to Russian Connection That Trump Was Falsely Accused of for Years

Nancy Guthrie neighbors’ Ring camera captures vehicles on possible route from crime scene

Family claims casino staff mistook veteran’s illness for intoxication, delaying care before his death

Retired Air Force Major Charged for Allegedly Training Chinese Military Pilots

New Texas Poll Is Out, and Stephen Colbert and Democratic Establishment Won’t Be Happy With It

Mamdani to meet with Trump in unannounced White House visit

China expands space footprint in Latin America, raising military alarms in America’s backyard

Biden FBI spied on Susie Wiles during Trump’s campaign

GOP pushes to hold sanctuary jurisdictions’ ‘feet to the fire’ in state where Laken Riley was killed

FBI subpoena of phone records leaves Trump chief of staff ‘in shock’: report

BREAKING: Clintons to Testify Separately Thursday and Friday in House Epstein Probe

Media Breakup: Jasmine Crockett’s Campaign Reportedly Calls Cops on CNN, Escorts Another Reporter Out of Rally

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”